Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model

被引:158
作者
Ha, Sang Keun [1 ]
Lee, Pyeongjae [2 ]
Park, Jeong A. [1 ]
Oh, Hye Rim [3 ]
Lee, Sang Yeon [1 ]
Park, Ji-Ho [1 ]
Lee, Eunjoo H. [1 ]
Ryu, Jong Hoon [3 ]
Lee, Kang Ro [4 ]
Kim, Sun Yeou [1 ]
机构
[1] Kyung Hee Univ, Grad Sch EW Med Sci, Kihung Ku, Yongin 449701, Kyungki Do, South Korea
[2] Semyung Univ, Dept Nat Med Resource, Jecheon City 390711, Chungbuk, South Korea
[3] Kyung Hee Univ, Dept Oriental Pharmaceut Sci, Seoul, South Korea
[4] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea
关键词
flavonoid; nitric oxide; apigenin; inflammation; prostaglandin E2; mitogen-activated protein kinase; middle cerebral artery occlusion;
D O I
10.1016/j.neuint.2007.10.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Flavonoids have been intensively studied on their pharmacological activities such as anti-cancer, anti-oxidant and anti-inflammation. However, little is known about their neuroprotective effects. Recent studies suggest that inflammation mediated by microglia may play a role in neurodegenerative diseases. In this study, we evaluated the anti-inflammatory effect of various flavonoid compounds by using BV-2, a murine microglia cell line. Of the compounds that were evaluated, apigenin inhibited the production of nitric oxide and prostaglandin E-2 by suppressing the expression of inducible nitric oxide synthase and cyclooxygenase-2 protein, respectively. Moreover, apigenin suppressed p38 mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK) phosphorylation without affecting the activity of extracellular signal-regulated kinase (ERK). Apigenin was also found to protect neuronal cells from injury in middle cerebral artery occlusion. (C) 2007 Published by Elsevier ltd.
引用
收藏
页码:878 / 886
页数:9
相关论文
共 50 条
[1]   Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin [J].
Al-Fayez, Mohammad ;
Cai, Hong ;
Tunstall, Richard ;
Steward, William P. ;
Gescher, Andreas J. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (06) :816-825
[2]   EVALUATION OF 2, 3, 5-TRIPHENYLTETRAZOLIUM CHLORIDE AS A STAIN FOR DETECTION AND QUANTIFICATION OF EXPERIMENTAL CEREBRAL INFARCTION IN RATS [J].
BEDERSON, JB ;
PITTS, LH ;
GERMANO, SM ;
NISHIMURA, MC ;
DAVIS, RL ;
BARTKOWSKI, HM .
STROKE, 1986, 17 (06) :1304-1308
[3]  
Bhat NR, 1998, J NEUROSCI, V18, P1633
[4]   Protective effect of N-(3-(aminomethyl benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation [J].
Cárdenas, A ;
De Alba, J ;
Moro, MA ;
Leza, JC ;
Lorenzo, P ;
Lizasoain, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 354 (2-3) :161-165
[5]  
CHAO CC, 1992, J IMMUNOL, V149, P2736
[6]  
Chen CC, 1999, MOL PHARMACOL, V55, P481
[7]   Inhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine-stimulated microglia [J].
Chen, CJ ;
Raung, SL ;
Liao, SL ;
Chen, SY .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (05) :957-965
[8]   Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide [J].
Chen, YC ;
Shen, SC ;
Chen, LG ;
Lee, TJF ;
Yang, LL .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (11) :1417-1427
[9]  
DeFranco A L, 1995, Prog Clin Biol Res, V392, P407
[10]  
del Zoppo G, 2000, BRAIN PATHOL, V10, P95